Second-quarter earnings more than doubled at US
health-care product maker Johnson & Johnson, the company said Monday.
Quarterly net income was 3.8 billion dollars, or 1.3 dollars a share. The New Jersey-based company attributed the higher earnings in part to the sale of its stake in Elan Corporation.
Revenue rose 8.5 per cent to 17.8 billion dollars year-on-year. Both earnings and revenue beat Wall Street's expectations, Bloomberg news reported.
Most Popular Stories
- PBS Series Examines America's Demographic Shift
- Tim Cook Has Proved That Apple is His Baby
- Why the Bond Market Isn't as Safe as You Think
- Lexus Luxury Compact Sedan Wins Buyers
- Review: Pay by Phone or Just Keep Using Plastic?
- Royals Beat A's in 12-inning Wild Card Thriller
- What to Look for in Mich. Jobs Market
- Construction Spending Down Again for August
- Dallas Parents Fear Students Exposed to Ebola
- Obama Seeks Traction From Economic Recovery